Pratik S Multani - Net Worth and Insider Trading

Pratik S Multani Net Worth

The estimated net worth of Pratik S Multani is at least $542,436 dollars as of 2024-04-24. Pratik S Multani is the Director of Erasca Inc and owns about 172,866 shares of Erasca Inc (ERAS) stock worth over $333,631. Pratik S Multani is also the Chief Medical Officer of ORIC Pharmaceuticals Inc and owns about 23,809 shares of ORIC Pharmaceuticals Inc (ORIC) stock worth over $208,805. Details can be seen in Pratik S Multani's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pratik S Multani has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).

Transaction Summary of Pratik S Multani

To

Pratik S Multani Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pratik S Multani owns 5 companies in total, including Chimerix Inc () , ORIC Pharmaceuticals Inc () , and Ignyta Inc () among others .

Click here to see the complete history of Pratik S Multani’s form 4 insider trades.

Insider Ownership Summary of Pratik S Multani

Ticker Comapny Transaction Date Type of Owner
Chimerix Inc 2020-02-21 director
ORIC Pharmaceuticals Inc 2023-12-15 Chief Business Officer
Ignyta Inc 2018-02-08 Chief Medical Officer
Fate Therapeutics Inc 2013-09-30 Chief Medical Officer
Erasca Inc 2021-07-20 director

Pratik S Multani Latest Holdings Summary

Pratik S Multani currently owns a total of 2 stocks. Among these stocks, Pratik S Multani owns 172,866 shares of Erasca Inc (ERAS) as of July 20, 2021, with a value of $333,631 and a weighting of 61.51%. Pratik S Multani also owns 23,809 shares of ORIC Pharmaceuticals Inc (ORIC) as of December 15, 2023, with a value of $208,805 and a weighting of 38.49%.

Latest Holdings of Pratik S Multani

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ERAS Erasca Inc 2021-07-20 172,866 1.93 333,631
ORIC ORIC Pharmaceuticals Inc 2023-12-15 23,809 8.77 208,805

Holding Weightings of Pratik S Multani


Pratik S Multani Form 4 Trading Tracker

According to the SEC Form 4 filings, Pratik S Multani has made a total of 1 transactions in Erasca Inc (ERAS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Erasca Inc is the acquisition of 6,200 shares on July 20, 2021, which cost Pratik S Multani around $99,200.

According to the SEC Form 4 filings, Pratik S Multani has made a total of 2 transactions in ORIC Pharmaceuticals Inc (ORIC) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in ORIC Pharmaceuticals Inc is the sale of 5,282 shares on December 15, 2023, which brought Pratik S Multani around $45,372.

Insider Trading History of Pratik S Multani

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pratik S Multani Trading Performance

GuruFocus tracks the stock performance after each of Pratik S Multani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pratik S Multani is 0.16%. GuruFocus also compares Pratik S Multani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pratik S Multani within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Pratik S Multani's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Pratik S Multani

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.05 0.16 -40.67 -59.02 -63.16
Relative Return to S&P 500(%) 6.31 -4.77 -44.36 -50.62 -65.58

Pratik S Multani Ownership Network

Ownership Network List of Pratik S Multani

No Data

Ownership Network Relation of Pratik S Multani


Pratik S Multani Owned Company Details

What does Chimerix Inc do?

Who are the key executives at Chimerix Inc?

Pratik S Multani is the director of Chimerix Inc. Other key executives at Chimerix Inc include Principal Accounting Officer David Jakeman , Chief Business Officer Michael T. Andriole , and director & Chief Executive Officer Michael A. Sherman .

Chimerix Inc () Insider Trades Summary

Over the past 18 months, Pratik S Multani made no insider transaction in Chimerix Inc (). Other recent insider transactions involving Chimerix Inc () include a net purchase of 60,000 shares made by Fred A Middleton , a net sale of 9,500 shares made by David Jakeman , and a net purchase of 87,000 shares made by Michael A. Sherman .

In summary, during the past 3 months, insiders sold 6,344 shares of Chimerix Inc () in total and bought 0 shares, with a net sale of 6,344 shares. During the past 18 months, 13,184 shares of Chimerix Inc () were sold and 173,750 shares were bought by its insiders, resulting in a net purchase of 160,566 shares.

Chimerix Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Chimerix Inc Insider Transactions

No Available Data

Pratik S Multani Mailing Address

Above is the net worth, insider trading, and ownership report for Pratik S Multani. You might contact Pratik S Multani via mailing address: C/o Fate Therapeutics, Inc., 3535 General Atomics Court, Suite 200, San Diego Ca 92121.

Discussions on Pratik S Multani

No discussions yet.